Literature DB >> 25190200

Genetics of Parkinson disease.

E Ben-David1, R Tu2.   

Abstract

Entities:  

Year:  2014        PMID: 25190200      PMCID: PMC8013069          DOI: 10.3174/ajnr.A4092

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  37 in total

Review 1.  Alzheimer's disease and Parkinson's disease.

Authors:  Robert L Nussbaum; Christopher E Ellis
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

2.  Did parkinsonism occur before 1817?

Authors:  G Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.

Authors:  Shalom Michaeli; Gülin Oz; Dennis J Sorce; Michael Garwood; Kamil Ugurbil; Stacy Majestic; Paul Tuite
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  [Prehistory of Parkinson's disease].

Authors:  P J García Ruiz
Journal:  Neurologia       Date:  2004-12       Impact factor: 3.109

Review 6.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

7.  Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.

Authors:  Zang-Hee Cho; Se-Hong Oh; Jong-Min Kim; Sung-Yeon Park; Dae-Hyuk Kwon; Hye-Jin Jeong; Young-Bo Kim; Je-Geun Chi; Chan-Woong Park; John Huston; Kendall H Lee; Beom S Jeon
Journal:  Mov Disord       Date:  2011-01-21       Impact factor: 10.338

8.  Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.

Authors:  F Binkofski; K Reetz; C Gaser; R Hilker; J Hagenah; K Hedrich; T van Eimeren; A Thiel; C Büchel; P P Pramstaller; H R Siebner; C Klein
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

9.  A clinical genetic study of Parkinson's disease: evidence for dominant transmission.

Authors:  A M Lazzarini; R H Myers; T R Zimmerman; M H Mark; L I Golbe; J I Sage; W G Johnson; R C Duvoisin
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

10.  Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.

Authors:  J M Gorell; R J Ordidge; G G Brown; J C Deniau; N M Buderer; J A Helpern
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  2 in total

Review 1.  The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases.

Authors:  Liang Qu; Chao Pan; Shi-Ming He; Bing Lang; Guo-Dong Gao; Xue-Lian Wang; Yuan Wang
Journal:  Front Mol Neurosci       Date:  2019-05-21       Impact factor: 5.639

Review 2.  Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.

Authors:  Hammad Ullah; Haroon Khan
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.